News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Conference Call Details
Pharmaxis Ltd (PXS) will release its December 2012 Quarterly Report to Shareholders on the afternoon of Wednesday 23rd January 2013. Pharmaxis CEO, Dr Alan Robertson, will host an investor teleconference the following morning to review the quarter and answer investor questions.
The teleconference will be on Thursday 24th January 2013 at 8.30am (Sydney time).
Online access: https://services.choruscall.com/links/pharmaxis130124.html
Telephone access (toll free):
- Australia: 1800 838 758 or 1800 131 617
- USA/Canada: 1855 237 2970
- UK: 0800 051 4282
- NZ: 0800 447 258
Telephone access (metered): +61 2 9009 0730
Bronchitol Approved by NICE in UK
Pharmaceutical company Pharmaxis (ASX: PXS) is pleased to announce that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has issued a positive recommendation in its Final Appraisal Determination for Bronchitol®, clearing the way for reimbursement by the National Health Service.
Read full media release - pdf